Company
United StatesPublic company, NASDAQ: OMEROmeros Corp (NASDAQ: OMER), Seattle, WA – FDA Inspections
Inspection records and compliance data for Omeros Corp in Seattle, Washington. 1 FDA inspection on record, last inspected January 14, 2021. Publicly traded as NASDAQ: OMER.
Company Profile
This profile covers Omeros Corp based in Seattle, Washington, United States.
FDA Inspection History
- FDA inspections
- 1
- OAI
- 0
- VAI
- 0
- NAI
- 1
- Form 483s
- 0
- Warning letters
- 0
Inspected January 14, 2021.
FDA inspections (1)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| January 14, 2021 | NAI | Human Drugs · Bioresearch Monitoring | 1135078 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Omeros Corp
Stock ticker
OMER
Exchange
NASDAQ
Share price
$17.11
Market cap
$1.2B
Price as of
November 6, 2026
FEI Number
3010219643
Address
201 Elliott Ave W, Seattle, Washington 98119, United States
Country
United States
ID: 389cfb56-03fc-4dfa-afa8-0084014f8661